Added to YB: 2024-10-25
Pitch date: 2024-10-25
AKBA [bullish]
Akebia Therapeutics, Inc.
+2.21%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.
Market Cap
$443.2M
Pitch Price
$1.58
Price Target
N/A
Dividend
N/A
EV/EBITDA
12.77
P/E
-25.78
EV/Sales
2.11
Sector
Biotechnology
Category
N/A
Show full summary:
AKEBIA THERAPEUTICS INC AKBA
A summary for this pitch has not been created yet.
Read full article (0 min)